Deep Learning-based HRCT Assessment of Baseline Disease Severity in the Deupirfenidone ELEVATE IPF Trial...American Thoracic Society (ATS) International Conference. 2026. Craster A, et al. [Poster]
Previous
Previous
Designing a Head-to-Head Trial in IPF. Pulmonary Clinical Trials Conference. 2026. Graham CS, et al. [Oral Presentation]
Next
Next